Specificity of JAK-kinase inhibition determines impact on human and murine T-cell function. (Q54254821)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Specificity of JAK-kinase inhibition determines impact on human and murine T-cell function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

T M Schnöder

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

S Ranjan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

D Wolleschak

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

C Ebert

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M C Pils

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

S Frey

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

A Polanetzki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

C Fahldieck

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

U Schönborn

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

B Schraven

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

B Isermann

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

T Fischer

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

F H Heidel

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

5 August 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

991-995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2015.218

20 February 2020

exact match

0 references

cites work

JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.218

Ruxolitinib versus standard therapy for the treatment of polycythemia vera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.218

Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.218

Cytokine signaling modules in inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.218

JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.218

Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.218

Disseminated tuberculosis in a patient treated with a JAK2 selective inhibitor: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.218

Bilateral toxoplasmosis retinitis associated with ruxolitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.218

An opportunistic infection associated with ruxolitinib, a novel janus kinase 1,2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.218

Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.218

Epo-induced erythroid maturation is dependent on Plcγ1 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.218

Clinically relevant doses of FLT3-kinase inhibitors quizartinib and midostaurin do not impair T-cell reactivity and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.218

Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26242463

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/LEU.2015.218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26242463%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference